$AMED
AMEDISYS INC

2012 Q4 Form 10-Q Financial Statement

#000119312512454105 Filed on November 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $350.2M $364.3M $370.3M
YoY Change -5.43% -1.62% -2.5%
Cost Of Revenue $197.8M $207.0M $202.1M
YoY Change -1.98% 2.41% 8.01%
Gross Profit $152.4M $157.4M $168.2M
YoY Change -9.55% -6.42% -12.76%
Gross Profit Margin 43.52% 43.21% 45.42%
Selling, General & Admin $134.1M $132.2M $139.3M
YoY Change -2.69% -5.1% 3.34%
% of Gross Profit 87.99% 83.99% 82.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.10M $9.900M $9.800M
YoY Change -5.61% 1.02% 11.36%
% of Gross Profit 6.63% 6.29% 5.83%
Operating Expenses $143.9M $142.0M $149.0M
YoY Change -2.77% -4.7% 4.34%
Operating Profit $8.500M $15.36M -$554.9M
YoY Change -58.54% -102.77% -1209.77%
Interest Expense -$5.400M $1.982M $2.187M
YoY Change 217.65% -9.37% -268.23%
% of Operating Profit -63.53% 12.9%
Other Income/Expense, Net $3.600M -$1.591M -$2.016M
YoY Change -21.08%
Pretax Income -$155.5M $13.77M -$556.9M
YoY Change -1296.15% -102.47% -1245.89%
Income Tax -$34.30M $3.332M -$134.7M
% Of Pretax Income 24.2%
Net Earnings -$106.8M $9.900M -$423.7M
YoY Change -2583.72% -102.34% -2061.57%
Net Earnings / Revenue -30.5% 2.72% -114.42%
Basic Earnings Per Share -$3.52 $0.33 -$14.73
Diluted Earnings Per Share -$3.52 $0.33 -$14.73
COMMON SHARES
Basic Shares Outstanding 30.94M shares 30.06M shares 28.77M shares
Diluted Shares Outstanding 30.42M shares 28.77M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.50M $39.10M $29.50M
YoY Change -69.79% 32.54% -76.95%
Cash & Equivalents $14.55M $39.11M $29.46M
Short-Term Investments
Other Short-Term Assets $11.44M $20.64M $24.80M
YoY Change -53.55% -16.79% 40.11%
Inventory
Prepaid Expenses $10.63M $10.65M
Receivables $169.2M $163.5M $151.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $205.8M $233.8M $205.4M
YoY Change -11.3% 13.85% -27.24%
LONG-TERM ASSETS
Property, Plant & Equipment $156.7M $150.9M $146.9M
YoY Change 5.5% 2.75% 24.7%
Goodwill $209.6M $367.5M
YoY Change -37.38%
Intangibles $47.00M $51.96M
YoY Change -6.0%
Long-Term Investments
YoY Change
Other Assets $18.65M $16.96M $106.4M
YoY Change -23.32% -84.06% 508.0%
Total Long-Term Assets $524.8M $641.9M $641.4M
YoY Change -16.2% 0.07% -34.66%
TOTAL ASSETS
Total Short-Term Assets $205.8M $233.8M $205.4M
Total Long-Term Assets $524.8M $641.9M $641.4M
Total Assets $730.6M $875.7M $846.8M
YoY Change -14.88% 3.42% -33.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.18M $21.69M $22.30M
YoY Change 14.52% -2.74% 13.78%
Accrued Expenses $54.86M $64.46M $145.0M
YoY Change -19.91% -55.54% -3.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $35.81M $54.31M $33.50M
YoY Change 5.66% 62.11% -14.76%
Total Short-Term Liabilities $204.8M $231.5M $209.5M
YoY Change -7.64% 10.48% -4.16%
LONG-TERM LIABILITIES
Long-Term Debt $66.90M $67.86M $119.7M
YoY Change -40.03% -43.31% -21.97%
Other Long-Term Liabilities $4.671M $4.431M $5.600M
YoY Change -3.73% -20.88% -20.0%
Total Long-Term Liabilities $71.57M $72.29M $125.3M
YoY Change -38.51% -42.31% -21.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $204.8M $231.5M $209.5M
Total Long-Term Liabilities $71.57M $72.29M $125.3M
Total Liabilities $276.4M $303.7M $336.2M
YoY Change -18.27% -9.65% -19.42%
SHAREHOLDERS EQUITY
Retained Earnings $18.62M $125.4M
YoY Change -81.78%
Common Stock $450.8M $446.2M
YoY Change 4.26%
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.12M $17.03M
YoY Change 8.54%
Treasury Stock Shares 789.9K shares 782.8K shares
Shareholders Equity $452.3M $554.7M $510.6M
YoY Change
Total Liabilities & Shareholders Equity $730.6M $875.7M $846.8M
YoY Change -14.88% 3.42% -33.0%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$106.8M $9.900M -$423.7M
YoY Change -2583.72% -102.34% -2061.57%
Depreciation, Depletion And Amortization $10.10M $9.900M $9.800M
YoY Change -5.61% 1.02% 11.36%
Cash From Operating Activities $15.60M $21.80M $27.80M
YoY Change -57.72% -21.58% -41.1%
INVESTING ACTIVITIES
Capital Expenditures -$16.10M -$12.00M -$12.60M
YoY Change 177.59% -4.76% -7.35%
Acquisitions
YoY Change
Other Investing Activities -$3.600M -$400.0K -$4.600M
YoY Change -41.94% -91.3% 1433.33%
Cash From Investing Activities -$19.80M -$12.30M -$17.20M
YoY Change 65.0% -28.49% 22.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $15.00M
YoY Change
Cash From Financing Activities -20.50M -7.500M -9.400M
YoY Change 225.4% -20.21% -55.66%
NET CHANGE
Cash From Operating Activities 15.60M 21.80M 27.80M
Cash From Investing Activities -19.80M -12.30M -17.20M
Cash From Financing Activities -20.50M -7.500M -9.400M
Net Change In Cash -24.70M 2.000M 1.200M
YoY Change -232.8% 66.67% -90.0%
FREE CASH FLOW
Cash From Operating Activities $15.60M $21.80M $27.80M
Capital Expenditures -$16.10M -$12.00M -$12.60M
Free Cash Flow $31.70M $33.80M $40.40M
YoY Change -25.76% -16.34% -33.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30941348 shares
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29462000
CY2012Q3 us-gaap Goodwill
Goodwill
367495000
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
446233000
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
20635000
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16963000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
554675000
CY2012Q3 us-gaap Other Notes Payable
OtherNotesPayable
7200000
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
571980000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
81751000
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
782753 shares
CY2012Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
9249000
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31640832 shares
CY2012Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
122200000
amed Historical Collection Rate On Medicare Claims
HistoricalCollectionRateOnMedicareClaims
0.99 pure
CY2011 amed Number Of Care Centers Closed
NumberOfCareCentersClosed
29 pure
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51959000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2012Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
20500000
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64460000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
231457000
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
54307000
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
67856000
CY2012Q3 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.5 pure
CY2012Q3 amed Total Leverage Ratio
TotalLeverageRatio
1.2 pure
CY2012Q3 amed Hospice Inpatient Units
HospiceInpatientUnits
2 pure
CY2012Q3 amed Number Of States With Facilities
NumberOfStatesWithFacilities
38 State
CY2012Q3 us-gaap Liabilities
Liabilities
303744000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21690000
CY2012Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10646000
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4431000
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
54512000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
125429000
CY2012Q3 us-gaap Assets
Assets
875724000
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
163461000
CY2012Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
875724000
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
122200000
CY2012Q3 us-gaap Minority Interest
MinorityInterest
17305000
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
17034000
CY2012Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
229500000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39106000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32423585 shares
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20447000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22745000
CY2012Q3 us-gaap Assets Current
AssetsCurrent
233848000
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105157000
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150947000
CY2012Q3 amed Medicare Certified Home Health Agencies
MedicareCertifiedHomeHealthAgencies
436 pure
CY2012Q3 amed Medicare Certified Hospice Agencies
MedicareCertifiedHospiceAgencies
97 pure
CY2012Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50 pure
CY2012Q3 amed Revolving Credit Facility Total
RevolvingCreditFacilityTotal
250000000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120295000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
148061000
CY2011Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2011Q4 us-gaap Goodwill
Goodwill
334695000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
432390000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
24630000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24322000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
518868000
CY2011Q4 us-gaap Other Notes Payable
OtherNotesPayable
7900000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
520148000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
82130000
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
688814 shares
CY2011Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
11748000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30328549 shares
CY2011Q4 us-gaap Liabilities
Liabilities
338137000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25475000
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11321000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4852000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
30000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
68649000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
102205000
CY2011Q4 us-gaap Assets
Assets
858285000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
858285000
CY2011Q4 us-gaap Long Term Debt
LongTermDebt
145400000
CY2011Q4 us-gaap Minority Interest
MinorityInterest
1280000
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15770000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48004000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31017363 shares
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50067000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68493000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
221734000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17438000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20611000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
232016000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
94266000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148536000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-4394000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38573000
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33888000
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
111551000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4394000
us-gaap Costs And Expenses
CostsAndExpenses
1582728000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.15
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3535000
us-gaap Operating Income Loss
OperatingIncomeLoss
-484702000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
116000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
814000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
125977000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
859000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
29674000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-843000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-382384000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-7200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28907000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
136228000
us-gaap Share Based Compensation
ShareBasedCompensation
8265000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-382268000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.53
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9918000
us-gaap Profit Loss
ProfitLoss
-386662000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
14900000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
245000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
574114000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104293000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-168663000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
225000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-90833000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4304000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3961000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8960000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28587000 shares
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1182000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5883000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-490899000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.53
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1098026000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26463000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1088000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-2800000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-13.38
us-gaap Cost Of Services
CostOfServices
578823000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28587000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1114000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
4500000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11273000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1796000
us-gaap Interest Paid
InterestPaid
7094000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-133623000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
544000 shares
us-gaap Net Income Loss
NetIncomeLoss
-386778000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6197000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
427000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
247175000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-108631000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-13.38
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
472000
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
1058000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1475000
us-gaap Interest Expense
InterestExpense
6693000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
568000
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Percent Of Net Services Revenue Provided By Medicare
PercentOfNetServicesRevenueProvidedByMedicare
0.85 pure
amed Term Loan Weighted Average Interest Rate
TermLoanWeightedAverageInterestRate
0.010 pure
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
9734000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
7900000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
391700000
amed Employee Match Expense
EmployeeMatchExpense
5845000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
28389000
dei Trading Symbol
TradingSymbol
AMED
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1218000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
194000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8744000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
239000
us-gaap Costs And Expenses
CostsAndExpenses
1082269000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Reclassifications and Comparability</i></b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain reclassifications have been made to prior periods&#x2019; financial statements in order to conform to the current period&#x2019;s presentation. During the quarter ended March&#xA0;31, 2012 and the year ended December&#xA0;31, 2011, we closed three and 29 care centers, respectively. In accordance with applicable accounting guidance, the results of operations for these care centers are presented in discontinued operations in our condensed consolidated financial statements. See Note 4 for additional information regarding our discontinued operations.</font></p> </div>
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-421000
us-gaap Operating Income Loss
OperatingIncomeLoss
42687000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25489000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
281000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
24442000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-2000000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30046000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
139941000
us-gaap Share Based Compensation
ShareBasedCompensation
6065000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
24642000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
483000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2934000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2875000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
609000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16286000
us-gaap Profit Loss
ProfitLoss
23424000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
100000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56904000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40249000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
52000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1218000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32198000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8898000
us-gaap Notes Issued1
NotesIssued1
2214000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30068000 shares
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1182000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31686000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38053000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1124956000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25553000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1050000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-800000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.82
us-gaap Cost Of Services
CostOfServices
634903000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29741000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1091000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1620000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1066000
us-gaap Interest Expense
InterestExpense
6058000
us-gaap Interest Paid
InterestPaid
6896000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11637000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
233000 shares
us-gaap Net Income Loss
NetIncomeLoss
23224000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4634000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3038000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
255203000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
32800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13411000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.81
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2">Our accounting and reporting policies conform with U.S. GAAP. In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></p> </div>
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
155000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10815000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
105000
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 PatientVisit
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60 D
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120 D
amed Cms Hospice Face To Face Requirement Prior To Third Benefit Period
CmsHospiceFaceToFaceRequirementPriorToThirdBenefitPeriod
30 D
amed Cms Therapy Assessment Requirement Interval Minimum
CmsTherapyAssessmentRequirementIntervalMinimum
30 D
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60 D
amed Episodes Of Progress That Begin During Reporting Period
EpisodesOfProgressThatBeginDuringReportingPeriod
60 D
amed Days In Hospice Recertification Third Benefit Period
DaysInHospiceRecertificationThirdBenefitPeriod
180 D
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 PatientVisit
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 PatientVisit
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365 D
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 PatientVisit
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Percent Of Net Services Revenue Provided By Medicare
PercentOfNetServicesRevenueProvidedByMedicare
0.82 pure
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10 pure
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.60 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.50 pure
amed Term Loan Weighted Average Interest Rate
TermLoanWeightedAverageInterestRate
0.012 pure
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.10 pure
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
311000 shares
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
400000
amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
4000000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
16235000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
7700000
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
800000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
401200000
amed Employee Match Expense
EmployeeMatchExpense
7575000
amed Term Loan Period
TermLoanPeriod
P5Y
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
29922000
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-172000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-554885000
CY2011Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
25000
CY2011Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-900000
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-14.68
CY2011Q3 us-gaap Cost Of Services
CostOfServices
202093000
CY2011 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.73 pure
CY2012Q1 amed Number Of Care Centers Closed
NumberOfCareCentersClosed
3 pure
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1482000
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
925173000
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
CY2011Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-422240000
CY2011Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-2400000
CY2011Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
46711000
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3150000
CY2011Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-422215000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.73
CY2011Q3 us-gaap Profit Loss
ProfitLoss
-423697000
CY2011Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
4600000
CY2011Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
574114000
CY2011Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
18000
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1482000
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28770000 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-556901000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.73
CY2011Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
370288000
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28770000 shares
CY2011Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
325000
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
925000 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-423722000
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2016000
CY2011Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
85092000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-134686000
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-14.68
CY2011Q3 us-gaap Interest Expense
InterestExpense
2187000
CY2011Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2011Q3 amed Percent Of Net Services Revenue Provided By Medicare
PercentOfNetServicesRevenueProvidedByMedicare
0.85 pure
CY2011Q3 amed Term Loan Weighted Average Interest Rate
TermLoanWeightedAverageInterestRate
0.010 pure
CY2011Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4354000
CY2011Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
3200000
CY2011Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
135000000
CY2011Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
9659000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-41000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
360944000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14681000
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
73000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9963000
CY2012Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
48261000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1285000
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
10036000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2012Q3 us-gaap Profit Loss
ProfitLoss
9995000
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000 shares
CY2012Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
10000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-41000
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30423000 shares
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13085000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2012Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
375625000
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.33
CY2012Q3 us-gaap Cost Of Services
CostOfServices
214131000
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30055000 shares
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
390000
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196000 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
9922000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1596000
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
81627000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3049000
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.33
CY2012Q3 us-gaap Interest Expense
InterestExpense
1982000
CY2012Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2012Q3 amed Percent Of Net Services Revenue Provided By Medicare
PercentOfNetServicesRevenueProvidedByMedicare
0.82 pure
CY2012Q3 amed Term Loan Weighted Average Interest Rate
TermLoanWeightedAverageInterestRate
0.013 pure
CY2012Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
348000 shares
CY2012Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
5677000
CY2012Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2700000
CY2012Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
131200000
CY2012Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
9963000

Files In Submission

Name View Source Status
0001193125-12-454105-index-headers.html Edgar Link pending
0001193125-12-454105-index.html Edgar Link pending
0001193125-12-454105.txt Edgar Link pending
0001193125-12-454105-xbrl.zip Edgar Link pending
amed-20120930.xml Edgar Link completed
amed-20120930.xsd Edgar Link pending
amed-20120930_cal.xml Edgar Link unprocessable
amed-20120930_def.xml Edgar Link unprocessable
amed-20120930_lab.xml Edgar Link unprocessable
amed-20120930_pre.xml Edgar Link unprocessable
d404907d10q.htm Edgar Link pending
d404907dex311.htm Edgar Link pending
d404907dex312.htm Edgar Link pending
d404907dex321.htm Edgar Link pending
d404907dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g404907g69o15.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending